NDC 80425-0303-01 - Buspirone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0303
- Requested NDC
- 80425-0303-01
- Package NDCs from labels
- 80425-0303-1, 80425-0303-2, 80425-0303-3, 80425-0303-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buspirone Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0303-1 | Buspirone Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 80425-0303-2 | Buspirone Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 80425-0303-3 | Buspirone Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0303 | BUSPIRONE HYDROCHLORIDE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f8afd9b8-0885-2f0c-e053-6294a90a9c57.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0303-1 | EA - Each | 80425-0303 | f4913649-e1ba-42f9-8427-a607b54d7ddf | 1 | 2023-06-06 |
| 80425-0303-2 | EA - Each | 80425-0303 | 37cb4f00-cf48-48e7-87f2-e17af97a0001 | 1 | 2023-06-06 |
| 80425-0303-3 | EA - Each | 80425-0303 | 9453aa87-69d6-4b8b-9098-5a9978f87ac7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | efa03f52-430e-455a-bdca-7f9d422b7b19 | 2019-01-08 | Warnings, Adverse reactions | 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | fac49d42-7bc0-435f-bce2-2548dcdd6de6 | 2018-12-20 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 310c6bea-838b-43e4-87e0-a0050829c242 | 2018-12-19 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | b7e3a98c-9ec5-4c21-9218-0d53a555a75c | 2018-11-08 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 8b6e7ae6-5b83-4a5a-ab45-cf4be4287d78 | 2018-10-18 | Warnings, Adverse reactions | 866094 207LT9J9OC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.